Aleta Biotherapeutics

aletabio.com

Actively hiring

As featured in

Yahoo Finance

Overview

News

Salaries

Products

People

Growth

Offices

Financials

Overview

Aleta's novel engager proteins transform cancers so that CAR-T cells can effectively kill every targeted tumor cell. Aleta Biotherapeutics is pioneering transformation of cancer treatment by enabling CAR T cancer therapies to work more effectively.

News

News YahooFinance 10 months ago

Aleta Biotherapeutics and Cancer Research UK Announce Promising Phase I/II Data from ALETA-001 Clinical Trial for Patients With Relapsed/Refractory B-Cell Malignancies Previously Treated with CD19 CAR T-Cell Therapy

NATICK, Mass. & LONDON, December 08, 2025--Aleta Biotherapeutics, a clinical stage immuno-oncology company developing CAR T-cell engager biologics that enable CAR T-cell cancer therapies to work more effectively, and Cancer Research UK's Centre for Drug D

Report